Live Breaking News & Updates on Bmrn

Stay updated with breaking news from Bmrn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Motley Fool Wealth Management LLC Reduces Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Motley Fool Wealth Management LLC trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 3.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 470,289 shares of the biotechnology company’s stock after selling 18,667 shares during the period. BioMarin Pharmaceutical makes up about 2.4% of Motley Fool Wealth […] ....

Erin Burkhart , Jean Jacques Bienaime , Piper Sandler , Securities Exchange Commission , Kb Financial Partners , Lindbrook Capital , Morgan Stanley , Holdings Channel , Canaccord Genuity Group , Wells Fargo Company , Motley Fool Wealth Management , Castleview Partners , Biomarin Pharmaceutical Inc , Biomarin Pharmaceutical , Free Report , Marin Pharmaceutical , Fool Wealth Management , Marin Pharmaceutical Stock Down , Get Free Report , Wells Fargo , Genuity Group , Exchange Commission , Director Jean Jacques Bienaime , Marin Pharmaceutical Inc , Visit Holdingschannel , Biomarin Pharmaceutical Daily ,

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $112.00 at Morgan Stanley

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective decreased by Morgan Stanley from $115.00 to $112.00 in a research note released on Friday, Benzinga reports. Morgan Stanley currently has an overweight rating on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the company. Cantor Fitzgerald reaffirmed […] ....

United States , Jeffrey Robert Ajer , Piper Sandler , Jean Jacques Bienaime , Alaska Department Of Revenue , Biomarin Pharmaceutical Inc , Morgan Stanley , Cantor Fitzgerald , Wells Fargo Company , Asset Management Corp , Simplicity Solutions , Canaccord Genuity Group , Securities Exchange Commission , Biomarin Pharmaceutical , Free Report , Wells Fargo , Moderate Buy , Marin Pharmaceutical , Get Free Report , Director Jean Jacques Bienaime , Exchange Commission , Robert Ajer , Alaska Department , Management Corp , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

Xponance Inc. Sells 203 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Xponance Inc. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,966 shares of the biotechnology company’s stock after selling 203 shares during the quarter. Xponance […] ....

Jean Jacques Bienaime , Erin Burkhart , Piper Sandler , Canaccord Genuity Group , Biomarin Pharmaceutical Inc , Wells Fargo Company , Royal Bank , Castleview Partners , Securities Exchange Commission , Cantor Fitzgerald , Kb Financial Partners , Xponance Inc , Exchange Commission , Biomarin Pharmaceutical , Free Report , Marin Pharmaceutical Stock Down , Marin Pharmaceutical , Get Free Report , Wells Fargo , Director Jean Jacques Bienaime , Marin Pharmaceutical Inc , Visit Holdingschannel , Biomarin Pharmaceutical Daily , Nasdaq Bmrn , Sec Filings , Hedge Fund Holdings ,

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $91.00 at Citigroup

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its target price lowered by Citigroup from $94.00 to $91.00 in a research note published on Thursday morning, Benzinga reports. Citigroup currently has a neutral rating on the biotechnology company’s stock. Several other research analysts have also issued reports on BMRN. Royal Bank of Canada restated a sector […] ....

Robertw Baird , Jeffrey Robert Ajer , Piper Sandler , Jean Jacques Bienaime , Royal Bank , Wells Fargo Company , First Horizon Advisors Inc , Biomarin Pharmaceutical Inc , Atria Wealth Solutions Inc , Securities Exchange Commission , Stratos Wealth Partners , Kb Financial Partners , Biomarin Pharmaceutical , Free Report , Moderate Buy , Marin Pharmaceutical Stock Down , Marin Pharmaceutical , Get Free Report , Director Jean Jacques Bienaime , Exchange Commission , Robert Ajer , Wealth Partners , Horizon Advisors , Atria Wealth Solutions , Wealth Solutions , Marin Pharmaceutical Inc ,